NewcelX Ltd. NCEL

Healthcare — Biotechnology

2.95 0.06 2.08% as of 25 Sep

Market cap: $15.6M
P/E: 0.0×

Follow NCEL

Insider Buys (last 12m)

Insider Buys alert about insiders buying in the last 12 month

Overview Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Dec '24	Jun '25	Dec '25	Jun '26
ROE Full definition →	+8 more TTM periods Free account	0.00%	0.00%	0.00%	0.00%
ROA Full definition →		0.00%	0.00%	0.00%	0.00%
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Average Days of Receivables Full definition →		—	—	—	—
Free Cash Flow per Share Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow Full definition →		(22.82)	(17.56)	(10.65)	(11.98)
Capital Expenditures Full definition →		(0.04)	—	(0.01)	—
Other line items
Cash ROIC Full definition →		310.09%	(294.81%)	(108.48%)	(167.71%)
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →		—	—	—	0.00%
Operating CF/Net income Full definition →		0.00	0.00	0.00	0.00
Depreciation/Fixed assets Full definition →		0.02	4.23	0.04	1.07
Capex/Depreciation Full definition →		(1.67)	0.00	(0.18)	0.00
Operating CF per Share Full definition →		0.00	0.00	0.00	0.00
Capex per Share Full definition →		0.00	—	0.00	—
Capex to Sales Full definition →		0.00	—	0.00	—

Fold the line items

Columns are period end dates